Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds

In the first clinical trial of its kind, US researchers found that people with late-life agitation and dementia who took a special medical formulation of two active ingredients found in marijuana – THC and CBD – had significantly less agitation than people who received a placebo.

Source link

Please follow and like us:
Pin Share

Leave a Reply

Your email address will not be published. Required fields are marked *